| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |